New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2014
08:58 EDTCOCO, DATA, XONE, DDD, CTSH, VJET, SSYS, OMER, MRK, RLOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Merck (MRK), up 1.6%... Ralph Lauren (RL), up 7%... Tableau Software (DATA), up 12%... Corinthian Colleges (COCO), up 2%. ALSO HIGHER: Omeros (OMER), up 11% after granted fast track designation to OMS824 by FDA. DOWN AFTER EARNINGS: Allergan (AGN), down xx%... Cognizant (CTSH), down 5%. ALSO LOWER: 3D Systems (DDD), down 15% after lowering FY13 EPS view, guiding FY14 below estimates. Peers Stratasys (SSYS), down 7.5%, ExOne (XONE), down 8%, and Voxeljet (VJET), down 7%, lower as well.
News For DDD;RL;SSYS;XONE;MRK;VJET;DATA;OMER;CTSH;COCO From The Last 14 Days
Check below for free stories on DDD;RL;SSYS;XONE;MRK;VJET;DATA;OMER;CTSH;COCO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
April 7, 2014
06:22 EDTDDD, XONE, SSYS3-D stocks off to a rough start in 2014, WSJ reports
3-D stocks are off to a rough start this year with 3D Systems (DDD) down 40% and Stratasys (SSYS) down about 19%, the Wall Street Journal reports, but adds that some 3-D stocks remain priced at 50-70 times projected 2014 earnings. Reference Link
April 6, 2014
13:37 EDTMRKMerck presents findings on clinical outcomes following treatment with MK-3475
Subscribe for More Information
April 4, 2014
09:22 EDTDDD3D Systems named Best Idea for 2014 at Stephens
Subscribe for More Information
08:31 EDTSSYSStratasys acquires Interfacial Solutions
Subscribe for More Information
08:07 EDTMRKMerck, Ferring announce collaboration with WHO
Merck and Ferring Pharmaceuticals announced their collaboration with the World Health Organization to advance a new, proprietary formulation of carbetocin, used to prevent excessive bleeding in women after childbirth, that is designed to be stable at room temperature, even in hot and tropical climates. Currently, oxytocin, the standard medicine administered for the prevention of excessive bleeding, is temperature-sensitive and requires sustained cold distribution and storage in hot climates. The WHO will conduct a multi-country clinical study to evaluate the effectiveness of room-temperature-stable carbetocin, as compared to oxytocin. The development of a medicine that can be stored at room temperature has the potential to significantly improve management of bleeding following childbirth in the many areas of the world where cold storage is difficult to achieve and maintain, and thereby help reduce maternal deaths in those areas. Starting this year, the study will take place in 12 countries around the world and enroll approximately 29,000 women. If the results of the study are positive, the organizations will work together with the aim of making the medicine available in developing countries that have a high burden of maternal mortality at an affordable and sustainable public-sector price.
07:57 EDTSSYSDeloitte Corporate advising Solid Conceps on sale to Stratasys
Subscribe for More Information
07:55 EDTDDD3D Systems checks indicate strong momentum, says Canaccord
Subscribe for More Information
April 3, 2014
12:34 EDTCOCOCorinthian Colleges sued by Massachusetts AG for deceptive practices
Massachusetts Attorney General Martha Coakley announced that Corinthian Colleges, which operates Everest Institute, has been sued over allegations that it misrepresented its training programs and job placement rates in order to increase profits, and pushed students into high-interest subprime loans. Reference Link
11:36 EDTVJET Options with decreasing implied volatility: RH APOL BBRY VJET RHT
Subscribe for More Information
10:46 EDTSSYSStratasys rises after analyst praises acquisitions
Subscribe for More Information
08:37 EDTSSYSStratasys deal enhances strategic positioning, says BB&T
Subscribe for More Information
07:40 EDTCOCOChanos says still short names in for-profit education space
Subscribe for More Information
07:30 EDTSSYS, XONE, VJETJefferies to hold a summit
Subscribe for More Information
07:08 EDTOMEROmeros' Investigational New Drug Application for OMS721 cleared by FDA
Subscribe for More Information
April 2, 2014
11:08 EDTVJETOptions with decreasing implied volatility: LULU VJET APOL RHT GME
Subscribe for More Information
10:00 EDTCTSHOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:37 EDTCTSHWells Fargo to hold a summit
Subscribe for More Information
08:15 EDTDDD3D Systems acquires Medical Modeling
Subscribe for More Information
06:22 EDTCTSHCognizant upgraded to Buy from Neutral at UBS
UBS upgraded Cognizant and said it is well positioned for the current demand environment as IT budgets are focused on cost optimization and believes discretionary project spending will be solid. The analyst expect Cognizant to announce a more formal capital return policy this year and views valuation as attractive. Price target raised to $58 from $50.
05:51 EDTSSYSStratasys to acquire Solid Concepts, Harvest Technologies
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use